Company Sernova Toronto S.E.

Stocks

SVA

CA81732W1041

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 15:30:05 02/10/2026 BST			5-day change	1st Jan Change
0.1050 ^CAD	-4.55%		+16.67%	-19.23%

09-10	Sernova Biotherapeutics Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026	CI
09-08	Seraxis Holdings, Inc. entered into a definitive agreement to acquire Sernova Biotherapeutics Inc in a merger of equals, reverse merger transaction.	CI

Business description: Sernova

Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.

Sales by Activity: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all business segments

Geographical breakdown of sales: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all geographic segments

Executive Committee: Sernova

Manager	Title	Age	Since
Jonathan Rigby CEO	Chief Executive Officer	58	11/08/2024
James Parsons DFI	Director of Finance/CFO	60	10/10/2024
David Burke IRC	Investor Relations Contact	-	10/10/2024
Marie Kaldchibachi PRN	Corporate Officer/Principal	-	-
Pericles Calias PRN	Corporate Officer/Principal	-	09/03/2025

See SERNOVA governance

Composition of the Board of Directors: Sernova

Director	Title	Age	Since
James Parsons BRD	Director/Board Member	60	18/04/2012
Steven Sangha BRD	Director/Board Member	-	23/04/2023
David Paterson BRD	Director/Board Member	-	31/08/2024
Bernd Mühlenweg BRD	Director/Board Member	54	31/03/2024
Tanya Lewis BRD	Director/Board Member	55	-
John Brooks CHM	Chairman	75	22/09/2025

Composition of the Board of Directors

Shareholders: Sernova

Name	Stocks	%	Valuation
Steven Sangha 10.51 %	39,703,667	10.51 %	3 M $
James Parsons 0.1627 %	614,605	0.1627 %	52 856 $
Jonathan Rigby 0.0609 %	229,877	0.0609 %	19 769 $
CATAM Asset Management AG 0.0397 %	150,000	0.0397 %	12 900 $
Archer Investment Corp. 0.003082 %	11,640	0.003082 %	1 001 $

List of SERNOVA shareholders

Company details: Sernova

Sernova Biotherapeutics, Inc.

700 Collip Circle

N6G 4X8, London

+917-751-5713

http://www.sernova.com

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABBOTT LABORATORIES	+0.84%	-3.74%	-26.69%	+1.85%	169B
MEDTRONIC PLC	-0.07%	-2.55%	-9.53%	+11.07%	110B
STRYKER CORPORATION	+0.90%	+1.13%	-24.83%	+0.58%	106B
ESSILORLUXOTTICA	-1.24%	-0.76%	-49.04%	-12.75%	73.87B
CENCORA, INC.	-0.24%	+0.69%	+0.16%	+72.58%	58.98B
HOYA CORPORATION	-0.86%	+2.96%	+13.57%	+59.50%	51.28B
BECTON, DICKINSON AND COMPANY	-0.71%	-3.82%	-7.72%	-31.41%	48.16B
IDEXX LABORATORIES, INC.	+0.12%	-0.17%	-18.21%	+20.29%	40.84B
DEXCOM, INC.	-1.01%	-1.45%	+28.48%	-9.72%	32.21B
Average	-0.25%	-0.86%	-10.42%	+12.44%	76.69B
Weighted average by Cap.	+0.03%	-1.30%	-16.36%	+10.13%